Literature DB >> 4364265

Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.

P Gunvén, G Klein, W Henle, G Henle, G Rocchi, J F Hewetson, A Guerra, P Clifford, S Singh, A Demissie, A Svedmyr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4364265     DOI： 10.1002/ijc.2910120112

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  3 in total

1.  Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.

Authors:  P Gunvén; G Klein; P Clifford; S Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

2.  Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.

Authors:  M Jondal; P Gunven
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

3.  Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.

Authors:  Ilona Argirion; Katie R Zarins; Krittika Suwanrungruang; Donsuk Pongnikorn; Imjai Chitapanarux; Hutcha Sriplung; Patravoot Vatanasapt; Laura S Rozek
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.